<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Immune Disorders</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/immune-disorders/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Possible Breakthrough in Battle against AIDS: Protein Fragment Blocks AIDS Virus Entry into Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/#comments</comments>
		<pubDate>Thu, 14 Apr 2011 08:00:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11442</guid>
		<description><![CDATA[Researchers worldwide are hailing a new discovery as being a possible breakthrough in the treatment for AIDS. Scientists have developed a new protein that stops the AIDS the virus from entering cells. This protein has a basic make-up of naturally occurring proteins in the body that protects cells from viruses, except the human-made version does [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Nanoparticles from MIT could lead to Vaccines for HIV, Malaria and Others</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/#comments</comments>
		<pubDate>Fri, 11 Mar 2011 08:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11275</guid>
		<description><![CDATA[While it might seem unbelievable, MIT engineers have announced that they have managed to design a new type of nanoparticles that could effectively and safely deliver vaccines for diseases such as malaria and HIV. HIV is known to be one of the biggest killers in the world and till now no one has been able [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Researchers &#8216;Unzip&#8217; MRSA&#8217;s Armor for Possible Vaccine</title>
		<link>http://pharmaexecnews.com/biotechnology/researchers-unzip-mrsas-armor-vaccine/</link>
		<comments>http://pharmaexecnews.com/biotechnology/researchers-unzip-mrsas-armor-vaccine/#comments</comments>
		<pubDate>Mon, 24 Jan 2011 08:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11099</guid>
		<description><![CDATA[MRSA (methicillin-resistant staphylococcus aureus) is one tough nut to crack. Researchers have failed to produce a vaccine because agents cannot break through the life-threatening bacteria&#8217;s armor. So, while other research has targeted the surface of the bacteria, a team from the University of Rochester Medical Center has discovered an antibody that reaches beyond the microbe&#8217;s [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/researchers-unzip-mrsas-armor-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First HIV &#8220;Cure&#8221; Comes with a Very Big Catch</title>
		<link>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/</link>
		<comments>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/#comments</comments>
		<pubDate>Wed, 22 Dec 2010 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11003</guid>
		<description><![CDATA[In a rare victory against AIDS, German scientists say that three years after a unique stem cell transplant was tried on a patient, &#8220;cure of HIV has been achieved in this&#8221; man. This is the first time anyone has been pronounced cured of the disease. But as New Scientist notes, their radical therapy strategy offers [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Backstabbing Bacteria: A New Treatment for Infection?</title>
		<link>http://pharmaexecnews.com/biotechnology/backstabbing-bacteria-treatment-infection/</link>
		<comments>http://pharmaexecnews.com/biotechnology/backstabbing-bacteria-treatment-infection/#comments</comments>
		<pubDate>Wed, 24 Nov 2010 08:00:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10914</guid>
		<description><![CDATA[Selfish bacterial cells that act in their own interests and do not cooperate with their infection-causing colleagues can actually reduce the severity of infection. The selfish behavior of these uncooperative bacteria could be exploited to treat antibiotic-resistant infections, according to research presented at the Society for General Microbiology&#8217;s autumn meeting.

Bacteria work together by using a [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/backstabbing-bacteria-treatment-infection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV Virus Hides in the Brain, Swedish Study Finds</title>
		<link>http://pharmaexecnews.com/biotechnology/hiv-virus-hides-brain-swedish-study-finds/</link>
		<comments>http://pharmaexecnews.com/biotechnology/hiv-virus-hides-brain-swedish-study-finds/#comments</comments>
		<pubDate>Wed, 22 Sep 2010 08:00:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[adenoviruses]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10725</guid>
		<description><![CDATA[Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood &#8212; a larger proportion than previously realized, reveals [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/hiv-virus-hides-brain-swedish-study-finds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Frances Wouldn&#8217;t Be Alive Without Cord Blood</title>
		<link>http://pharmaexecnews.com/biotechnology/frances-alive-cord-blood/</link>
		<comments>http://pharmaexecnews.com/biotechnology/frances-alive-cord-blood/#comments</comments>
		<pubDate>Mon, 20 Sep 2010 08:00:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10715</guid>
		<description><![CDATA[Doctors once suggested her parents take her home to die, but a young Auckland girl&#8217;s winning determination to fight off cancer &#8211; and the unique treatment that helped &#8211; is now being used to save other lives. In 2007, Frances Everall, just four years of age, was not expected to survive an aggressive stage four [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/frances-alive-cord-blood/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nearly 400 Medicines and Vaccines in Development to Fight Infectious Diseases</title>
		<link>http://pharmaexecnews.com/biotechnology/400-medicines-vaccines-development-fight-infectious-diseases/</link>
		<comments>http://pharmaexecnews.com/biotechnology/400-medicines-vaccines-development-fight-infectious-diseases/#comments</comments>
		<pubDate>Tue, 14 Sep 2010 08:00:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10699</guid>
		<description><![CDATA[Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America&#8217;s biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/400-medicines-vaccines-development-fight-infectious-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Researchers get $21M to Study HIV</title>
		<link>http://pharmaexecnews.com/biotechnology/researchers-21m-study-hiv/</link>
		<comments>http://pharmaexecnews.com/biotechnology/researchers-21m-study-hiv/#comments</comments>
		<pubDate>Thu, 26 Aug 2010 08:00:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[adenoviruses]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10648</guid>
		<description><![CDATA[A team headed by researchers from the Salk Institute for Biological Studies and the Sanford-Burnham Medical Research Institute has been awarded a $21 million grant to ascertain how the immune system reacts immediately after it is exposed to the AIDS virus. The project will bring together the expertise of 13 research groups at seven institutions [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/researchers-21m-study-hiv/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>WHO Declares H1N1 Pandemic Alert Over</title>
		<link>http://pharmaexecnews.com/biotechnology/declares-h1n1-pandemic-alert/</link>
		<comments>http://pharmaexecnews.com/biotechnology/declares-h1n1-pandemic-alert/#comments</comments>
		<pubDate>Mon, 16 Aug 2010 08:00:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10627</guid>
		<description><![CDATA[World Health Organization (WHO) Director-General, Dr. Margaret Chan, announced that the world is no longer in phase six of influenza pandemic alert &#8212; we are now moving into the post-pandemic period and the new H1N1 virus has largely run its course. Dr. Chan went on to say: “As we enter the post-pandemic period, this does [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/declares-h1n1-pandemic-alert/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

